Natera, Inc.
NTRANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 10/30206% above fair value
$378.92−35.38 (-8.54%)
Close on Nov 2, 2026Market cap $54.62BP/E –Yield –
Natera Construction in Progress by Year
Construction in Progress — Lab Expansion & Automation ($M) ($M)
Natera Construction in Progress: $94.0M in FY2025, up 60.8% from a year earlier. That is the highest of the 9 years on record here.
Latest, FY2025
94.0
Period ended Dec 31, 2025
Change on a year earlier
+60.8%
58.5 in FY2024
History
9 years
Since FY2017
Sources
9
Documents cited below
Where the FY2025 figure comes from
Source: Form 10-Q (2026-08-07) ↗
Reported in Form 10-K/10-Q Note — Balance Sheet Components (XBRL).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Construction in Progress — Lab Expansion & Automation ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 94.0 | +60.8% | Form 10-Q (2026-08-07) ↗ |
| FY2024 | Dec 31, 2024 | 58.5 | +98.9% | Form 10-K (2026-02-27) ↗ |
| FY2023 | Dec 31, 2023 | 29.4 | +15.8% | Form 10-K (2025-02-28) ↗ |
| FY2022 | Dec 31, 2022 | 25.4 | -16.2% | Form 10-K (2024-02-29) ↗ |
| FY2021 | Dec 31, 2021 | 30.3 | +375.4% | Form 10-K (2023-03-01) ↗ |
| FY2020 | Dec 31, 2020 | 6.37 | -17.5% | Form 10-K (2022-02-25) ↗ |
| FY2019 | Dec 31, 2019 | 7.72 | +92.5% | Form 10-K (2021-02-26) ↗ |
| FY2018 | Dec 31, 2018 | 4.01 | -38.3% | Form 10-K (2020-03-02) ↗ |
| FY2017 | Dec 31, 2017 | 6.50 | – | Form 10-K (2019-03-15) ↗ |
Cite this data
StockData. (2026). Natera Construction in Progress ($M), annual FY2017–FY2025 [Data set]. Compiled from Natera SEC filings and investor materials. https://stockdatahq.com/stocks/ntra/kpis/ppe-gross-cip
See every metric in the Natera KPI table. Data updated Nov 2, 2026.